DIET ATEROGENIK PADA TIKUS PUTIH (Rattus novergicus strain Wistar) SEBAGAI MODEL HEWAN ATEROSKLEROSIS
DOI:
https://doi.org/10.21776/ub.jkb.2006.022.01.2Abstract
Atherosclerosis is still a major health problem, because 20% of death in the world is caused by atherosclerosis diseases like stroke and myocardial infarct. One of animal models that was successful in atherosclerosis research was New Zealand white rabbit. The purpose of this preliminary research was to determine the atherogenic diet ofwhite rats (Rattus novergicus strain Wistar) as animal model of atherosclerosis especially to find fixed composition and time of the atherogenic diet taken.This research used male; 2 months age, 150-200 grams body weight of white rats Rattus novergicus strain Wistar. The rats were divided into5 groups in equal number, 4 rats respectively. Theywere a negative control group without diet treatment and 4 groups as treatment groups which were given hipercholesterol diet. Atherogenic diet composed of PAR-S, wheat flour, cholesterol, cholic acid, pork oil and water. Data were obtained by measuring of blood cholesterol level and foam cell formation.Downloads
References
Ameli S, Hultgradh-Nilson A, Nilson J. Effect of Immunization with Homologous LDL and Oxidized LDL on Early Atherosclerosis in Hipercholesterolemic Rabbits. Atherosclerosis, Thrombosis, and Vascular Biology,1997;16(8):1074-1079
Orford, JL and Selwyn AP. Atherosclerosis. Instant Access to the Mind of Medicine, Medicine. Department of Internal Medicine, Brigham an Women’s Hospital, Harvard Medical School, 2005
Worthley SG, Osende JI, Helft G, Badimon, JJ, Fuster, V. Coronary Artery Disease: Pathogenesis and Acute Coronary Syndrome. The Mount Sinai Journal of Medicine, 2001; 68: 3
Boyle JJ. Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture. Curr Vasc Pharmacol, 2005;3(1):63-68
Orford JL. Atherosclerosis. Clinical and Research Fellow in Cardiovascular Disease, Departement of Internal Medicine, Brigham and Women’s Hospital, Harvard Medical School, 2005
Sherer Y and Schoenfeld Y. Report on the European Atherosclerosis Society Workshop on the Immune System in Atherosclerosis. http://www.rheuma21st.com/archives/schoenfeld_immune_sys_atherosclerosis%20.html, 2001
Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Biochemitry23rd edition. USA: Prentice Hall International Inc., 1997
Chan P and Tomlison B. Treating Hypercholesterolemia. Medical Progress 1997; 24(4)
Srivastava RAK, Srivastava N, Averna M. Dietary Cholic Acid Lower Plasma Levels of Mouse and Human Apolipoprotein A-I Primarily Via Transcriptional Mechanism.Eur.J.Biochem 2000;267:4272-4280
Hansson GK. Cell-Mediated Immunity in Atherosclerosis. Journal of Cardiovascular Risk 1997; 4(5/6): 301-311
Aviram M and Fuhrman B. LDL Oxidation by Arterial Wall Macrophag Depends onThe Oxidative Status in The lipoprotein and The Cells : Role of Prooxidation vs Antioxidant. Mol Cell Biochem 1998; 188(1-2):149-159
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
